23 May 2013
Keywords: lilly/daiichi, sankyo, prasugrel, cuts, cv, aes, vs
Article | 21 November 2007
US drug major Eli Lilly reported positive findings from a late-stage trial of its antiplatelet drug prasugrel, showing that it ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 November 2007
19 November 2007
© 2013 thepharmaletter.com